FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

424402004: Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3682835014 Glimepiride 4 mg and rosiglitazone maleate 4 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3682836010 Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2641597010 Rosiglitazone 4mg/glimepiride 4mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2645703014 Rosiglitazone 4mg/glimepiride 4mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3471182016 Product containing rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3487302012 Product containing rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3502129010 Rosiglitazone 4 mg and glimepiride 4 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3570456017 Product containing only rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3570457014 Product containing only rosiglitazone 4 mg and glimepiride 4 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3682834013 Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3682835014 Glimepiride 4 mg and rosiglitazone maleate 4 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3682836010 Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Is a Product containing glimepiride and rosiglitazone (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glimepiride (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet (dose form) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone maleate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glimepiride (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Glimepiride (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength numerator value quatre false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Rosiglitazone maleate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Rosiglitazone maleate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength numerator value quatre false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength numerator unit (attribute) mg false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient Glimepiride (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient Rosiglitazone maleate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Is a Glimepiride- and rosiglitazone-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Is a Glimepiride and rosiglitazone only product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient Rosiglitazone maleate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Rosiglitazone maleate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has precise active ingredient Glimepiride (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Product containing precisely glimepiride 4 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) Glimepiride (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator attribute value reference set (foundation metadata concept)

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start